Summary:
Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.
Qualified Participants Must:
• Be between 18 to 65 years of age
•
Have Epilepsy partial seizures
•
Currently be taking 1 to 3 antiepileptic drugs
•
Not have pre-existing eye diseases (glaucoma)
•
Not have an insufficient response to pregabalin in the treatment of partial seizure
•
Not currently be receiving pregabalin treatment
Qualified Participants May Receive:
Study medication or study related visits at no cost. In addition, transportation is covered at no cost. Possible compensation for each completed visit for time and travel